Publications

Journal Article
Research Support, Non-U.S. Gov't
Epublish 54 citations
Electronic publication date
December 19, 2006

View on Pubmed.gov 17134490 | View on doi.org 10.1186/1471-21...

Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.

Search for publications in this journal BMC Mol Biol

Abstract

BACKGROUND

Macrophages (Mtheta) play a central role in the innate immune response and in the pathology of chronic inflammatory diseases. Macrophages treated with Th2-type cytokines such as Interleukin-4 (IL-4) and Interleukin-13 (IL-13) exhibit an altered phenotype and such alternatively activated macrophages are important in the pathology of diseases characterised by allergic inflammation including asthma and atopic dermatitis. The CC chemokine Thymus and Activation-Regulated Chemokine (TARC/CCL17) and its murine homologue (mTARC/ABCD-2) bind to the chemokine receptor CCR4, and direct T-cell and macrophage recruitment into areas of allergic inflammation. Delineating the molecular mechanisms responsible for the IL-4 induction of TARC expression will be important for a better understanding of the role of Th2 cytokines in allergic disease.

RESULTS

We demonstrate that mTARC mRNA and protein are potently induced by the Th2 cytokine, Interleukin-4 (IL-4), and inhibited by Interferon-gamma (IFN-gamma) in primary macrophages (Mtheta). IL-4 induction of mTARC occurs in the presence of PI3 kinase pathway and translation inhibitors, but not in the absence of STAT6 transcription factor, suggesting a direct-acting STAT6-mediated pathway of mTARC transcriptional activation. We have functionally characterised eleven putative STAT6 sites identified in the mTARC proximal promoter and determined that five of these contribute to the IL-4 induction of mTARC. By in vitro binding assays and transient transfection of isolated sites into the RAW 264.7 Mtheta cell-line, we demonstrate that these sites have widely different capacities for binding and activation by STAT6. Site-directed mutagenesis of these sites within the context of the mTARC proximal promoter revealed that the two most proximal sites, conserved between the human and mouse genes, are important mediators of the IL-4 response.

CONCLUSION

The induction of mTARC by IL-4 results from cooperative interactions between STAT6 sites within the mTARC gene promoter. Significantly, we have shown that transfer of the nine most proximal mTARC STAT6 sites in their endogenous conformation confers potent (up to 130-fold) IL-4 inducibility on heterologous promoters. These promoter elements constitute important and sensitive IL-4-responsive transcriptional units that could be used to drive transgene expression in sites of Th2 inflammation in vivo.

References

EMBO J. 1996 Oct 15;15(20):5616-26

J Biol Chem. 1997 Jun 6;272(23):15036-42

J Biol Chem. 1997 Dec 12;272(50):31821-8

Mol Immunol. 2003 Sep;40(1):35-47

Cited by 54 citations (total)

Journal Article Research Support, Non-U.S. Gov't

IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential.

Electronic publication date November 18, 2018

Search for publications in this journal Sci Rep

Sonia Boulakirba [...] Arnaud Jacquel et al.

CSF-1 and IL-34 share the CSF-1 receptor and no differences have been reported in the signaling pathways triggered by both...

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.

Electronic publication date March 26, 2021

Search for publications in this journal Am J Respir Cell Mol Biol

Teresa C Williams [...] Nathan W Bartlett et al.

The interplay of type-2 inflammation and antiviral immunity underpins asthma exacerbation pathogenesis. Virus infection induces type-2 inflammation-promoting chemokines CCL17 and...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances